Weight Loss ADOCIA Announces M1Pram Phase 2 Trial Meets Primary Objective by Reducing Weight in Overweight People with Type 1 DiabetesBy adminJune 21, 20220 Lyon, France-(Business wire)-Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC) (Paris: ADOC) is a clinical stage biopharmaceutical company focused on…
